here to read the piece in its entirety.

By: William Lin, Director of Corporate Contributions at Johnson & Johnson Reprinted from InterActions Aid Buzz

Last month in Geneva, leaders from government, business and non-governmental organizations met to continue the development of the strategy to coordinate efforts to combat one of the most prevalent – yet preventable – infectious conditions in the world. Intestinal worms, also known as soil transmitted helminthes or STH, affect nearly one in four people on the planet, and until recently, bringing the condition under control seemed like a daunting task. However, with the recent commitment of medicines from Johnson & Johnson and GSK, reaching the 600 million school-age children that are at risk suddenly became an attainable goal.